Soleno Therapeutics to Participate in Upcoming Investor Conferences
| Event: | |
| Day: | |
| Time: | |
| Event: | Goldman Sachs 45th Annual Global Healthcare Conference |
| Day: | |
| Time: | |
A live audio webcast and replay of the events will be available in the Investors section on the Company’s website at www.soleno.life.
About Soleno Therapeutics, Inc.
Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company’s lead candidate, DCCR extended-release tablets, a once-daily oral tablet for the treatment of PWS, recently completed its Phase 3 development program to support a planned NDA submission. For more information, please visit www.soleno.life.
Corporate Contact:
212-915-2578
Source: Soleno Therapeutics